A Phase II Trial of Triapine® (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2013
At a glance
- Drugs OCX 191 (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.